We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-13.18%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$86.6M
AUM Growth
-$19M
Cap. Flow
-$7.16M
Cap. Flow %
-8.26%
Top 10 Hldgs %
77.71%
Holding
93
New
35
Increased
1
Reduced
9
Closed
28

Top Buys

Rank Stock Value
1
SCOR icon
Comscore
SCOR
+$29.2M
2
CARM
Carisma Therapeutics
CARM
+$12.1M
3
EMWP
Eros Media World PLC
EMWP
+$10.8M
4
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$5.04M
5
CALA
Calithera Biosciences, Inc
CALA
+$4.79M

Top Sells

Rank Stock Value
1
NSTG
NanoString Technologies, Inc.
NSTG
+$18.5M
2
BPMC
Blueprint Medicines
BPMC
+$16M
3
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$8.16M
4
GNFT
Genfit
GNFT
+$6.12M
5
SYRE icon
Spyre Therapeutics
SYRE
+$2.19M

Sector Composition

Rank Sector Weight
1 Healthcare 32.81%
2 Technology 16.82%
3 Consumer Staples 4.12%
4 Communication Services 3.85%
5 Industrials 1.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOLO
76
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
– –
-194,653
Closed -$693K
NSTG
77
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-774,068
Closed -$18.5M
NOVN
78
DELISTED
Novan, Inc. Common Stock
NOVN
– –
-7,152
Closed -$68K
IMV
79
DELISTED
IMV Inc. Common Shares
IMV
– –
-2,966
Closed -$119K
NVCN
80
DELISTED
Neovasc Inc.
NVCN
– –
-203
Closed -$21K
SIOX
81
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-767,300
Closed -$8.16M
IMRNW
82
DELISTED
Immuron Limited Warrants
IMRNW
– –
-10,941
Closed -$15K
ADXS
83
DELISTED
Advaxis Inc
ADXS
– –
-210,570
Closed -$1.24M
UUUU.WS
84
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
+277,777
New +$383K
SHSP
85
DELISTED
SharpSpring, Inc.
SHSP
– –
-15,131
Closed -$242K
CHMA
86
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-61,805
Closed -$321K
TRPX
87
DELISTED
Therapix Biosciences Ltd.
TRPX
– –
-31,397
Closed -$98K
VLRX
88
DELISTED
VALERITAS HOLDINGS INC
VLRX
– –
-5,342
Closed -$35K
APDNW
89
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$0 ﹤0.01%
31,407
– –
NVIV
90
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
-99
Closed -$116K
1 2 3
4

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2019 Portfolio in Review

As of Q2 2019, CVI Holdings held 93 positions worth $86.6M, down 18% from $106M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $7.16M in Q2 2019, closing 28 positions and reducing 9 holdings. Its most notable exit was NanoString Technologies, Inc., an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 68% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, CVI Holdings opened a new position in Comscore worth $14.1M.

  • CVI Holdings's largest Q2 2019 buy was Comscore: 136,426 shares worth $14.1M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2019, an estimated $10.8M increase.
  • CVI Holdings's biggest Q2 2019 reduction was Genfit, cutting an estimated $6.12M.
  • CVI Holdings fully exited NanoString Technologies, Inc. in Q2 2019, selling an estimated $18.5M.
  • CVI Holdings's ten largest holdings make up 78% of its $86.6M portfolio in Q2 2019.
  • CVI Holdings opened 35 new positions and closed 28 in Q2 2019.
  • CVI Holdings's portfolio value fell 18% quarter-over-quarter to $86.6M.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.